baber/WOPTO huggingface dataset:
Patent NZ-561728-A (NZ)
Title: Ventilation board of multi-layer material with ventilation passageways between non-aligned and non-overlapping apertures in adjacent layers
Inventor: MEHTA VINAY K
IPC: B31B50/00
Filed: 2005-06-07
Abstract: The present disclosure relates to a ventilation board, an insulating board, a ventilation system, and articles and architectural applications comprising said ventilation board and a method of manufacturing the ventilation board. The said ventilation board comprises a layer (11) provided with a first aperture (5); an adjacent layer provided (13) with a second aperture (7), the first and second apertures being located relative to each other such that they are non-aligned and are substantially without overlap; and a passageway (9) interconnecting the first and second apertures thereby permitting the passage of fluid therebetween. Therefore, the carton comprising said ventilation board when used for fast food packaging provides sufficient ventilation of the carton so that water condensed from food vapours does not run on to the food in the carton, and sufficient insulation so that the food in the carton is kept warm.
Patent NZ-564586-A (NZ)
Title: Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
IPC: C12N1/21
Filed: 2002-11-20
Abstract: Disclosed is a vector having an adenovirus capsid, said capsid comprising a simian adenoviral Pan-5 hexon protein having the amino acid sequence of SEQ ID NO: 3, a sequence having at least 95 to 99% identity with SEQ ID NO: 3, said vector further comprising a heterologous gene operatively linked to sequences which direct expression of said gene in a host cell.
Patent NZ-564952-A (NZ)
Title: Low pungency onion requiring 14 hours (or more) of daylight to initiate bulb formation
Inventor: HENDRICKS SCOTT
IPC: C12N15/82
Filed: 2006-07-14
Abstract: Provided is an onion cultivar requiring 14 or more contiguous hours of daylight to initiate bulb formation comprising a bulb having less than 5.5 ìM pyruvic acid/gram fresh weight (ìM/g FW pyruvate) at harvest, wherein said bulb is capable of being stored for two months under suitable conditions without an increase in PAD of greater than 20%. Further provided are breeding methods to obtain such plants.
Patent NZ-565698-A (NZ)
Title: Container closure assembly with cylindrical internal formation of cap forming seal with sealing member containing reservoir
Inventor: RAMSEY CHRISTOPHER PAUL
IPC: B65D51/28
Filed: 2006-07-27
Abstract: A closure assembly has a closure cap adapted to be fitted to the neck of a container to close the container. The cap has an upper wall (4) and a cylindrical skirt (5) depending therefrom. A reservoir (7) is formed on the underside of the upper wall (4) radially within the skirt (5) and has a dispensing opening. A sealing member (3) is fitted into the closure cap to close the dispensing opening in the reservoir. When the assembly is fitted to the container the sealing member fits into the neck of the container with an interference fit such that when the closure cap is removed from the container, the sealing member (3) remains held within the neck of the container and is separated from the closure cap so that the dispensing opening is opened and material contained therein is dispensed into the container.
Patent NZ-569668-A (NZ)
Title: Microbicidal composition comprising N-methyl-1,2-benzisothiazolin-3-one
Inventor: ASHMORE JOHN WILLIAM
IPC: A01N31/02
Filed: 2008-07-08
Abstract: Disclosed is a microbicidal composition comprising N-methyl-1,2-benzisothiazolin-3-one (MBIT), Cu(II) 2-aminoethanolate and didecyl dimethyl ammonium chloride, wherein the ratio of Cu(II) 2-aminoethanolate and didecyl dimethyl ammonium chloride to MBIT is from 1:176 to 1:0.08. Also disclosed is a microbicidal composition comprising MBIT and Cu(II) 2-aminoethanolate, wherein the ration Cu(II) 2-aminoethanolate to MBIT is from 1:375 to 1:0.004.
Patent NZ-579262-A (NZ)
Title: Therapeutic applications of activation of human antigen-presenting cells through dectin-1
Inventor: BANCHEREAU JACQUES F
IPC: C12N5/0784
Filed: 2008-02-22
Abstract: Disclosed is the use of an anti-Dectin-1-specific antibody or functional fragment thereof in conjunction with one or more antigens, wherein the anti-Dectin-1-specific antibody or functional fragment thereof is capable of activating a Dectin-1-expressing antigen presenting cell in the manufacture of a medicament for treating a disease selected from viral disease, bacterial diseases, fungal diseases, protozoa diseases, parasitic diseases, tumours, autoimmune diseases, allergies or graft rejection, wherein the one or more antigens are selected from the group consisting of viral antigens, bacterial antigens, fungal antigens, protozoal antigens, parasitic antigens, tumor antigens, antigens involved in autoimmune disease, antigens involved in allergy, and antigens involved in graft rejection. The effectiveness of antigen presentation by the antigen presenting cell is increased by contacting the antigen presenting cell with the anti-Dectin-1-specific antibody or functional fragment thereof, wherein the antigen presenting cells comprise an isolated dendritic cell, a peripheral blood mononuclear cell, a monocyte, a B cell, a myeloid dendritic cell, or combinations thereof. The anti-Dectin-1-specific antibody or fragment thereof is a specific for the ectodomain of Dectin-1.
Patent NZ-583858-A (NZ)
Title: Lacrimal implant detection with detection device
Inventor: DE JUAN EUGENE JR
IPC: A61F9/007
Filed: 2008-09-05
Abstract: A lacrimal implant insertable at least partially into a lacrimal punctum, comprises an implant core 410, and an implant body, where the implant body includes a cavity 340 sized and shaped to receive the implant core 410. At least one of the implant core 410 and the implant body comprises a detection device configured to allow detection of the lacrimal implant with a separate detector device
Patent NZ-588062-A (NZ)
Title: Child safety seat where the harness is in a path of variable length on a rear side of the back portion
Inventor: MACIEJCZYK WIESLAW
IPC: A47D1/10
Filed: 2010-09-17
Abstract: A child safety seat (1) comprising a seat body (2) with a base (4) and a back portion (6) is disclosed. The seat (1) further comprises a harness (20) that is routed along on a path of variable length on a rear side of the back portion (6) through to a front side of the back portion (6).
Patent NZ-589241-A (NZ)
Title: Instrument cleaner using a protease and phenoxy alcohol
Inventor: KRITZLER STEVEN
IPC: A01N63/50
Filed: 2009-05-06
Abstract: Disclosed is a composition for cleaning medical or dental instruments including a protease and a biostatically effective phenoxy alcohol at a concentration below its MIC against Pseudomonas aeruginosa (ATCC 15442), wherein the composition is effective to reduce a 6 log concentration of Pseudomonas aeruginosa (ATCC 15442) by at least a log concentration within 4 hours, the composition further comprising boron or a boron compound.
Patent NZ-590552-A (NZ)
Title: Method and apparatus for broadcasting notifications of natural disasters
Inventor: EKEMARK SVEN
IPC: H04W4/90
Filed: 2009-03-06
Abstract: 590552 Disclosed is a method and apparatus in a first communication device in a telecommunications network. An emergency notification is received from a broadcasting unit, indicating a cell associated to the first communication device, wherein the emergency notification is notified to user equipment. A paging channel is determined that is to be used to page and broadcast a notification indicating an emergency, the broadcast being within the cell. The notification indicating an emergency is ordered to be transmitted on the paging channel. A common control channel, to be used to broadcast an emergency confirm message within the cell, is determined and the emergency confirm message is ordered to be transmitted on the common control channel.
Patent NZ-598504-A (NZ)
Title: A ca6 antigen-specific cytotoxic conjugate and methods of using the same
Inventor: PAYNE GILLIAN
IPC: C12N5/06
Filed: 2004-07-21
Abstract: 598504 CA6 ANTIGEN-SPECIFIC CYTOTOXIC CONJUGATE AND METHODS OF USING THE SAME Provided is a method of detecting CA6 glycotope expression comprising: (a) contacting a sample with a non-murine antibody of specified sequence or epitope-binding fragment thereof, (b) detecting the binding of the non-murine antibody, or epitope-binding fragment thereof, of (a) to the CA6 glycotope in said sample. The method can be used to diagnose cancer patients.
Patent NZ-600379-A (NZ)
Title: Morphinan derivatives for the treatment of drug overdose
Inventor: SILVERMAN BERNARD
IPC: A01N43/42
Filed: 2010-10-13
Abstract: Disclosed herein is the use of a compound of Formula I, wherein the variables are defined in the specification, in the treatment of drug toxicity or overdose in a subject. Specifically wherein the subject is an opioid experiences non-dependent opioid user. Additionally disclosed is the use of a first opioid receptor antagonist followed by use of a compound of Formula I, wherein the variables are defined in the specification, in the treatment of opioid toxicity or overdose in a subject. Specifically wherein said first opioid receptor antagonist is naloxone. Specifically wherein the compound is a malate salt.
Patent NZ-603769-A (NZ)
Title: Reinforced post
Inventor: OLSSON ASHLEY DEAN
IPC: E04H17/08
Filed: 2012-11-21
Abstract: A reinforced post (1) comprising a ground-anchorable Y-shaped or T-shaped steel post (2) and a steel reinforcing member (3) connected to the post (2). The Y-shaped post (2) has a longitudinal body (4) and three arms (5, 6, 7) extending radially from the longitudinal body (4). The reinforcing member (3) is in the form of a steel strengthening strip or plate (3) that is welded at or near ends of at least two of the arms of the post. The reinforcing member extends between the arms (6, 7) of the post (2) and is not co-planar with any of the arms. The strip or plate (3) is capable of increasing the bending resistance of the post (2) at ground level. The strip or plate (3) stops the post arms (6, 7) from splaying or folding outwards under compressive stress due to force being applied to the Y -shaped post (2) above ground level.
Patent NZ-605088-A (NZ)
Title: Il-13 producing tr1-like cells and use thereof
Inventor: FOUSSAT ARNAUD
IPC: A61K35/12
Filed: 2011-06-30
Abstract: Disclosed is an isolated human Tr1 cell population capable of producing IL-13 when activated, wherein said Tr1 cell population secretes an amount of IL-13 of more than 10ng/ml. Also disclosed is an in vitro method of identifying said human Tr1 cell population, comprising: - detecting the cell surface expression of CD4, and at least one of CD127 and CD62L markers on a cell population, - detecting the production of IL-13, or IL13 and IL-10, wherein the cells expressing CD4 and a low level of CD127 and/or a low level CD62L and producing 1) more than 10ng/mL IL-13 when activated or 2) IL-10 and more than 10ng/mL IL-13 when activated, are the IL-13 producing Tr1 cell population.
Patent NZ-608273-A (NZ)
Title: Inductive power transfer system and method
Inventor: JOHN TALBOT BOYS
IPC: H02J17/00
Filed: 2011-12-16
Abstract: Disclosed is a foreign object detection apparatus for an IPT system. The apparatus comprises a control means operable to detect the presence of a foreign object on or adjacent to an IPT primary pad of the system by detecting a reduction in magnitude of the short circuit current in a secondary pad which receives power inductively from the primary pad. Measurements of reactive power in a primary of the system may also be used to detect foreign objects.
Patent NZ-612189-A (NZ)
Title: Improvements to growing assemblies
Inventor: FLOWERDAY WILLIAM VINCENT
IPC: A01G17/06
Filed: 2009-07-24
Abstract: 612189 A growing assembly for kiwifruit vines is disclosed. The assembly comprises a structure (8A-C) configured to provide a support for a plants (7) and a secondary support (19A) positioned above and extending along the length of the structure. A plurality of paths extends between the structure (8A-C) and the secondary support (19A) along which the plant may grow away from the structure (8). The secondary support (19A) is configured to move through an arcuate path to lower the plurality of paths and facilitate transferring the plant growing along the plurality of paths onto the structure (8A-C). The secondary support (19A) is held on a pair of pivoting arms (10) having an engagement point below the pivot (see Fig. 6) to facilitate moving and/or holding the arms (10) in place.
Patent NZ-621155-A (NZ)
Title: Plant disease control composition and its use
Inventor: MATSUZAKI YUICHI
IPC: A01P3/00
Filed: 2011-09-26
Abstract: Disclosed is a composition comprising a carboxamide compound of formula (I) and the fungicide ethaboxam, wherein the substituents of formula (I) are as defined in the specification. Also disclosed is the use of the composition for controlling plant disease.
Patent NZ-628300-A (NZ)
Title: Anti-spalling edging
Inventor: ARNOLD RODNEY MALCOLM
IPC: E04C5/18
Filed: 2013-02-22
Abstract: An anti-spalling edging for a concrete slab is disclosed. The edging comprises a metal strip (21, 31) to cast the concrete slab (S2, S3) against. A return (22, 32) extends along a top edge of the strip (21, 31) to form a corner. The far edge of the return spaced from the strip (21, 31) is turned down and has cut-outs (26, 36) in it for anchoring in the concrete. An elongate metallic member (101,102) extends along the corner and is fixed to the strip and/or the return to reinforce the anti-spalling edge at the corner. The cut outs (26, 36) allow concrete to fill up to the reinforcing member (101, 102) when the slab is poured. The reinforcing member (101, 102) maintains the return (22, 23) in position when the surface of the slab begins break up under heavy repetitive loading. Two edgings can be used to form a joint between adjacent slabs (S2, S3)
Patent NZ-629730-A (NZ)
Title: Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
Inventor: MACDONALD LOCH R
IPC: A61P25/00
Filed: 2014-03-11
Abstract: Provided are compositions and their use to treat complications of aneurysmal subarachnoid haemorrhage, such as angiographic vasospasm. In a preferred embodiment the composition contains microparticles comprising poly(lactide-co-glycolide) (PLGA) polymer and nimodipine, and as a carrier hyaluronic acid having a molecular weight of from about 5 kDa-20 0000 kDa.
Patent NZ-631318-A (NZ)
Title: Method of weight management
Inventor: SHANAHAN WILLIAM R
IPC: A61P3/04
Filed: 2012-11-06
Abstract: Disclosed is the use of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine or a pharmaceutically acceptable salt, solvate or hydrate thereof in the manufacture of a medicament for therapeutic treatments including weight management, decreasing food intake, inducing satiety or treating obesity, wherein: -the medicament is provided for oral administration at a dose of 20mg per day -the medicament is provided for administration in combination with a reduced-calorie diet -the subject has been selected for treatment as previously having been determined to have achieved at least 5% weight loss within 12 weeks of treatment with (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine at a dose of 20mg, and whereby achievement of at least 5% weight loss by week 12 correlates with a likelihood of the individual achieving an additional decrease in assessment of weight after about one year -wherein the subject has an initial BMI of over 27 prior to treatment
Patent NZ-708801-A (NZ)
Title: Aryl and heteroaryl fused lactams
Inventor: SUTTON SCOTT CHANNING
IPC: C07D407/14
Filed: 2013-12-05
Abstract: This invention relates to compounds of general formula (II-A), or a pharmaceutically acceptable salt thereof, wherein: R1 is C1-C4 alkyl or halo; R2 is 5-6 membered heteroaryl optionally substituted by 1 to 3 R32; R3 is H; R4 is H or halo; m is 0 and R5 is absent; each R32 is independently -Cl, -F, -OH, -CH3, -CH2CH3, -CF3, -CH2OH, -CH2OCH3, -OCH3, -OC2H5, -OCF3, -CN, -C(O)NH2, -C(O)NHCH3, -C(O)N(CH3)2, -NHC(O)CH3, -NH2, -NHCH3, -N(CH3)2, cyclopropyl, 4-6 membered heterocyclyl, phenyl or 5-6 membered heteroaryl, where said 4-6 membered heterocyclyl, phenyl or 5-6 membered heteroaryl are optionally substituted by 1 to 3 halo, C1-C4 alkyl or C1-C4 alkoxy, which are independently selected; X and Z are independently C1-C4 alkyl; and Y is H. The invention also relates to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.
Patent NZ-709085-A (NZ)
Title: A dust filtration system of gas mixture of high temperature oil gas, water vapor and precipitation-prone carbides
Inventor: ZHU SHUCHENG
IPC: B01D46/00
Filed: 2015-06-12
Abstract: The present invention discloses a dust filtration system of gas mixture of high temperature oil gas, water vapor and precipitation-prone carbides, which comprises a closed separation chamber connecting intake duct and exhaust duct. The closed separation chamber comprises a filter mechanism inside, the outer surface of the filter mechanism connects to the intake duct and the inner surface connects to the exhaust duct, and the dust filtration system comprises a filter regeneration mechanism. The present invention includes a filter regeneration mechanism set in the closed separation chamber connecting intake duct and exhaust duct, which can recover the filtering capacity greatly decreased due to the adhesion of tar and ash to the filter surface and pores. The repeated regeneration directly reduces the cost of filter and greatly improves its service life. The filter regeneration mechanism further comprises a physical contact cleaning and brushing component and a regenerated gas intake and exhaust control component.
Patent NZ-710433-A (NZ)
Title: Authentication of security documents and mobile device to carry out the authentication
Inventor: LOHWEG VOLKER
IPC: G07D7/20
Filed: 2014-02-04
Abstract: A method of authenticating security documents and a mobile device, especially a smartphone, programmed to carry out the method, based on an analysis of features which are produced by intaglio printing, which analysis involves a decomposition of sample images of a candidate document to be authenticated based on Wavelets, each sample image being digitally processed by performing a Wavelet transform of the sample image in order to derive a set of classification features. The method is based on an adaptive approach, which includes the following steps : - prior to carrying out the Wavelet transform, defining a categorization map containing local information about different intaglio line structures that are found on the security documents; - carrying out a Wavelet selection amongst a pool of Wavelet types based on the categorization map; and - performing the Wavelet transform of the sample image on the basis of the selected Wavelet.
Patent NZ-718430-A (NZ)
Title: Heterocyclic compounds and uses thereof
Inventor: EVANS CATHERINE
IPC: C07D471/04
Filed: 2014-10-03
Abstract: The invention provides compounds of Formula (I) and pharmaceutical compositions thereof that modulate kinase activity, including PI3 kinase activity. For the compounds of formula (I), R1 is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; and Wd is a mono or bicyclic heteroaryl ring as defined herein. The PI3 kinase activity of the compounds makes them useful for the treatment of conditions such as cancers, bone disorders and respiratory diseases (e.g. COPD), inflammatory diseases or auto-immune diseases. In a preferred embodiment the compound of formula (I) is selected from (S)-N-(1-(8-((1-methyl-pyrazol-4-yl)ethynyl)-2-phenyl-1-oxo-isoquinolin-3-yl)-ethyl)-2-amino-pyrazolo[1,5-a]pyrimidine-3-carboxamide, (S)-N-(1-(8-((pyrazol-4-yl)ethynyl)-2-phenyl-1-oxo-isoquinolin-3-yl)-ethyl)-2-amino-pyrazolo[1,5-a]pyrimidine-3-carboxamide or (S)-N-(1-(5-((1,5-dimethyl-pyrazol-4-yl)ethynyl)-3-phenyl-4-oxo-quinazolin-2-yl)-ethyl)-2-amino-pyrazolo[1,5-a]pyrimidine-3-carboxamide.
Patent NZ-724364-A (NZ)
Title: A barrow
Inventor: HIESTAND BERNARD ANTON
IPC: B62B1/20
Filed: 2015-02-19
Abstract: A barrow (1) includes a tray (2); one or more wheels (12); one or more removable handles (16), each including a first handle coupling (40); one or more leg units (15), each including a leg (17) having a folded position in which the leg is folded against the tray and an unfolded position in which the leg extends downwards from the tray; and one or more second handle couplings (41) each configured to couple with one of the first handle couplings (40) to attach one of the one or more removable handles (16) to the barrow; wherein attachment of the one or more removable handles (16) to the barrow locks the one or more legs (17) in the unfolded position. The barrow may be convertible between a barrow configuration and a trailer configuration. The problem this invention solves is facilitating a conversion of the barrow into another configuration, such as a trailer.
Patent NZ-752024-A (NZ)
Title: Microfluidic system and method with focused energy apparatus
Inventor: APPLEYARD DAVID
IPC: G01N15/14
Filed: 2014-06-18
Abstract: The present invention relates to a microfluidic system which has applicability in, but not limited to, the biological and medical fields, for e.g., in sperm blood and other cellular material discrimination, including viral, cell organelle, globular structures, colloidal suspensions, and other biological materials. The present invention comprises a interrogation apparatus where the objects are arranged for identification in a fluid channel in a microfluidic chip, detected and interrogated to determine their identity in a sample fluid mixture, and a focused energy apparatus which performs an action that affects targeted objects by damaging, killing, altering, disabling, or destroying the targeted objects. Consequently, according to an embodiment the present system is capable of delivering continuous high throughput, is time and cost effective, and causes negligible or minimal damage to the various target objects.